Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
Date:3/26/2009

ontains forward-looking statements, including, but not limited to, statements related to Jazz Pharmaceuticals' ability to fund its operations on an ongoing basis, financing and strategic alternatives for the company, the status of the company's senior secured notes and potential partnering arrangements for certain of the company's programs. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Jazz Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to the company's default on its senior secured notes, the right of the note holders to accelerate the obligations at any time, the company's potential need to seek protection under the provisions of the U.S. Bankruptcy Code in the event of an acceleration of the senior secured notes or otherwise and the resulting risk to the stockholders' receipt of any value for their shares; the company's need to raise additional funds; product sales and revenues; and the cost and results of product development and clinical trials. These and other risk factors are discussed under "Risk Factors" in the Annual Report on Form 10-K for the year ended December 31, 2008 filed by Jazz Pharmaceuticals with the Securities and Exchange Commission on March 26, 2009. Jazz Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

                            JAZZ PHARMACEUTICALS, INC.
                       CONSOLIDATED STATEMENTS OF OPERATIONS
                     (In thousands, except per share amounts)
                                    (Unaudited)

                                        Three Mo
'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... 2015 , ... Shortly after opening her second practice in Signal Hill, Dr. ... on a lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, ... refugees, Dr. Lim suffered with back pain herself throughout high school. Unaware of ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... care from nurses or midwives, yet there is a large gap between the ... midwifery research required to improve health outcomes and reduce unnecessary or ineffective treatments ...
(Date:7/6/2015)... ... 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a value ... a CAGR of over 3.2 percent in the years to come to hit the ... spurred by an anticipated launch of a number of promising pipeline candidates and an ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the new ICD-10 requirements ... leading the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in ... ICD-10. The ten tips are timely and relevant guidelines to help radiology practices ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site ... and other serious medical conditions. Screenings are affordable and accurate and run about ...
Breaking Medicine News(10 mins):Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... April 1, 2009 (BRONX, NY) Scientists at Albert ... sweeping new theory of autism that suggests that the brains ... symptoms of the disorder might be reversible. , ... issue of Brain Research Reviews , is that autism ...
... 1 Patients with schizoaffective disorder who received ... weeks showed significant improvement in a broad range ... presented today at the 12th International Congress on ... findings of the study provide additional evidence for ...
... Va., April 1 On April 1st, Professional Healthcare ... to patients in their homes. The company was started ... agency, and has grown to an organization offering home ... District of Columbia, and Virginia. The company has over ...
... cancer patients to avoid the risks of surgeryDETROIT, April ... was on her way to Florida to escape the ... stereotactic body radiotherapy (SBRT) for recurrent ovarian cancer just ... had no qualms about authorizing the trip."It thrilled me, ...
... the wake of climate change and semi-arid regions turn ... world are likely to be displaced. A mathematical approach ... of Mathematics and Operational Research . , Decision scientist ... and colleagues Ruhul Sarker of the University of New ...
... This release is available in Spanish . ... the study of working memory. In terms of information ... is affected in diseases such as Alzheimer, and short-term ... decisions or structure a discourse. This more ephemeral memory ...
Cached Medicine News:Health News:Einstein scientists propose new theory of autism 2Health News:Einstein scientists propose new theory of autism 3Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 2Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 3Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 4Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 5Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 6Health News:Study Suggests Treatment with Paliperidone ER Significantly Improves Symptoms of Schizoaffective Disorder 7Health News:Professional Healthcare Resources Celebrates 15 Year Anniversary 2Health News:Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery 2Health News:Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery 3Health News:Doctors at Henry Ford Health System Treat Ovarian, Prostate, Lung, and Other Forms of Cancer Using Novalis Tx(TM) Platform for Image-Guided Radiosurgery 4Health News:Relocation, relocation, relocation 2Health News:Activation of the prefrontal cortex improves working memory 2
(Date:7/6/2015)... July 6, 2015  Impax Laboratories, Inc. (NASDAQ: ... its second quarter 2015 financial results on Monday, August ... financial markets. The Company will host a conference call ... a.m., Eastern Time on August 10, 2015. ... through the Investor Relations section of the Company,s Web ...
(Date:7/6/2015)... , July 6, 2015 ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy platform, ... Japan,s Ministry of Health, Labor ... Laser Endomicroscopy solution, the AQ-Flex 19 miniprobe.   ... AQ -Flex™ 19 miniprobe is comprised of a ...
(Date:7/6/2015)... , July 6, 2015  Protiviti, a global consulting ... Internal Auditing around the World publication ( www.protiviti.com/iaworld ... and reported on the evolution of the internal audit ... the globe as a means to providing senior executives ... this strategic business function. The 2015 edition ...
Breaking Medicine Technology:Impax to Report Second Quarter 2015 Results on August 10, 2015 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2
... , , SCOTTSDALE, Ariz., July 15 ... for many who fear Alzheimer,s disease . Now a ... New England Journal of Medicine suggests that the carriers of a common ... their mid-50s, far earlier than previously thought. , , ...
... , , , NEW YORK, ... today announced approximately $2.1 million in total funding to 10 research ... , Target validation is an essential ... to determine whether a molecule or mechanism of interest is a ...
Cached Medicine Technology:Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 2Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 3Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 4Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 5Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 6Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 7Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets 2Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: